Annelize Koch

735 total citations
24 papers, 550 citations indexed

About

Annelize Koch is a scholar working on Clinical Psychology, Immunology and Molecular Biology. According to data from OpenAlex, Annelize Koch has authored 24 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Psychology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Annelize Koch's work include Eating Disorders and Behaviors (6 papers), Pharmaceutical studies and practices (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Annelize Koch is often cited by papers focused on Eating Disorders and Behaviors (6 papers), Pharmaceutical studies and practices (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Annelize Koch collaborates with scholars based in United Kingdom, United States and Italy. Annelize Koch's co-authors include Edward T. Bullmore, Pradeep J. Nathan, Barry V. O’Neill, Chris Dodds, Antonella Napolitano, Emilio Merlo‐Pich, Paul C. Fletcher, Massimo Bani, Brendan P. Bradley and Tanvir Walele and has published in prestigious journals such as Biological Psychiatry, Kidney International and Psychopharmacology.

In The Last Decade

Annelize Koch

23 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annelize Koch United Kingdom	14	146	127	123	91	75	24	550
Anna‐Greta Nylander Denmark	17	186 1.3×	181 1.4×	92 0.7×	62 0.7×	45 0.6×	33	905
Dallas Forshew United States	17	120 0.8×	157 1.2×	147 1.2×	220 2.4×	22 0.3×	25	1.5k
Bettina Mesplès France	16	80 0.5×	115 0.9×	49 0.4×	38 0.4×	76 1.0×	25	832
G. K. Stalla Germany	16	82 0.6×	79 0.6×	25 0.2×	77 0.8×	82 1.1×	27	771
Christopher John United Kingdom	11	84 0.6×	102 0.8×	150 1.2×	40 0.4×	32 0.4×	25	489
Jennifer Kuo United States	8	106 0.7×	149 1.2×	40 0.3×	24 0.3×	34 0.5×	19	612
Gregory K.W. Lam United States	7	74 0.5×	177 1.4×	21 0.2×	164 1.8×	84 1.1×	11	629
Bram P. Prins United Kingdom	13	38 0.3×	197 1.6×	42 0.3×	81 0.9×	18 0.2×	20	699
Adithya Balasubramanian United States	16	55 0.4×	134 1.1×	27 0.2×	99 1.1×	48 0.6×	65	602

Countries citing papers authored by Annelize Koch

Since Specialization

Citations

This map shows the geographic impact of Annelize Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annelize Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annelize Koch more than expected).

Fields of papers citing papers by Annelize Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annelize Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annelize Koch. The network helps show where Annelize Koch may publish in the future.

Co-authorship network of co-authors of Annelize Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Annelize Koch. A scholar is included among the top collaborators of Annelize Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annelize Koch. Annelize Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clack, Glen, Christopher M. Moore, Linette Ruston, et al.. (2024). A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants. Advances in Therapy. 42(1). 216–232. 1 indexed citations

Höppe, Bernd, Annelize Koch, Pierre Cochat, et al.. (2021). Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria. Kidney International. 101(3). 626–634. 67 indexed citations

Albayaty, Muna, James Bush, Joseph Cheriyan, et al.. (2020). The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges. Frontiers in Pharmacology. 11. 580560–580560.

Reijntjes, Susan, Muna Albayaty, James Bush, et al.. (2018). The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development. Frontiers in Pharmacology. 9. 1301–1301. 1 indexed citations

Walele, Tanvir, et al.. (2017). Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting. Regulatory Toxicology and Pharmacology. 92. 226–238. 56 indexed citations

Helmer, Eric, Mark Watling, Emma Jones, et al.. (2017). First-in-human studies of seletalisib, an orally bioavailable small-molecule PI3Kδ inhibitor for the treatment of immune and inflammatory diseases. European Journal of Clinical Pharmacology. 73(5). 581–591. 13 indexed citations

Patel, Ameera X., Sam R. Miller, Pradeep J. Nathan, et al.. (2014). Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and Alprazolam following insulin-induced hypoglycemia in humans. Psychopharmacology. 231(19). 3817–3828. 8 indexed citations

O’Neill, Barry V., Edward T. Bullmore, Sam Miller, et al.. (2012). The relationship between fat mass, eating behaviour and obesity-related psychological traits in overweight and obese individuals. Appetite. 59(3). 656–661. 16 indexed citations

Dodds, Chris, Barry V. O’Neill, John D. Beaver, et al.. (2012). Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters. Appetite. 59(1). 27–33. 29 indexed citations

10.

Chamberlain, Samuel R., Karin Mogg, Brendan P. Bradley, et al.. (2012). Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals. Psychopharmacology. 224(4). 501–509. 21 indexed citations

11.

Cambridge, Victoria C., Hisham Ziauddeen, Pradeep J. Nathan, et al.. (2012). Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People. Biological Psychiatry. 73(9). 887–894. 68 indexed citations

12.

Mogg, Karin, Brendan P. Bradley, Barry V. O’Neill, et al.. (2012). Effect of dopamine D3 receptor antagonism on approach responses to food cues in overweight and obese individuals. Behavioural Pharmacology. 23(5 and 6). 603–608. 29 indexed citations

13.

McHugh, Simon, Shilina Roman, Annelize Koch, et al.. (2012). Effects of genetic variation in the P2RX7 gene on pharmacodynamics of a P2X₇ receptor antagonist: a prospective genotyping approach. British Journal of Clinical Pharmacology. 74(2). 376–380. 18 indexed citations

14.

Beaumont, Claire, Steve Thomas, Darren Robertson, et al.. (2011). Use of Entero‐Test, a simple approach for non‐invasive clinical evaluation of the biliary disposition of drugs. British Journal of Clinical Pharmacology. 72(1). 133–142. 23 indexed citations

15.

Nathan, Pradeep J., Mark Bush, Annelize Koch, et al.. (2011). Multiple‐Dose Safety, Pharmacokinetics, and Pharmacodynamics of the μ‐Opioid Receptor Inverse Agonist GSK1521498. The Journal of Clinical Pharmacology. 52(10). 1456–1467. 15 indexed citations

16.

Pugh, Nicholas, Gavin E. Jarvis, Annelize Koch, et al.. (2011). The impact of factor Xa inhibition on axial dependent arterial thrombus formation triggered by a tissue factor rich surface. Journal of Thrombosis and Thrombolysis. 33(1). 6–15. 2 indexed citations

17.

Nathan, Pradeep J., Barry V. O’Neill, Karin Mogg, et al.. (2011). The effects of the dopamine D3 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. The International Journal of Neuropsychopharmacology. 15(2). 149–161. 46 indexed citations

18.

Nathan, Pradeep J., Barry V. O’Neill, Mark Bush, et al.. (2011). Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist. The Journal of Clinical Pharmacology. 52(4). 464–474. 44 indexed citations

19.

Roberts, Claire, Annelize Koch, Odile Dewit, et al.. (2011). A Randomized, Controlled Study Comparing the Effects of Vestipitant or Vestipitant and Paroxetine Combination in Subjects With Tinnitus. Otology & Neurotology. 32(5). 721–727. 11 indexed citations

20.

Koch, Annelize, et al.. (1991). Experimental investigations on the influence of anemia on gentamicin ototoxicity. European Archives of Oto-Rhino-Laryngology. 248(6). 342–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact